SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19153121
Source:
http://linkedlifedata.com/resource/pubmed/id/19153121
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0008976
,
umls-concept:C0024623
,
umls-concept:C0030705
,
umls-concept:C0205179
,
umls-concept:C0205390
,
umls-concept:C0671970
,
umls-concept:C1708063
pubmed:issue
4
pubmed:dateCreated
2009-3-26
pubmed:abstractText
To compare capecitabine/cisplatin with 5-fluorouracil/cisplatin as first-line treatment for advanced gastric cancer (AGC).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19153121-19321659
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19153121-19759187
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/capecitabine
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1569-8041
pubmed:author
pubmed-author:ChenJJ
,
pubmed-author:ForsterGG
,
pubmed-author:GuanZZ
,
pubmed-author:KangW-KWK
,
pubmed-author:KangY-KYK
,
pubmed-author:KhasanovRR
,
pubmed-author:LichinitserMM
,
pubmed-author:McCloudP IPI
,
pubmed-author:Philco-SalasMM
,
pubmed-author:SantamariaJJ
,
pubmed-author:SiseJ AJA
,
pubmed-author:SuarezTT
,
pubmed-author:WangJJ
,
pubmed-author:XiongJJ
,
pubmed-author:ZhengLL
pubmed:issnType
Electronic
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
666-73
pubmed:dateRevised
2009-11-27
pubmed:meshHeading
pubmed-meshheading:19153121-Adult
,
pubmed-meshheading:19153121-Aged
,
pubmed-meshheading:19153121-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:19153121-Cisplatin
,
pubmed-meshheading:19153121-Deoxycytidine
,
pubmed-meshheading:19153121-Disease-Free Survival
,
pubmed-meshheading:19153121-Female
,
pubmed-meshheading:19153121-Fluorouracil
,
pubmed-meshheading:19153121-Humans
,
pubmed-meshheading:19153121-Male
,
pubmed-meshheading:19153121-Middle Aged
,
pubmed-meshheading:19153121-Stomach Neoplasms
,
pubmed-meshheading:19153121-Survival Analysis
pubmed:year
2009
pubmed:articleTitle
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.
pubmed:affiliation
Division of Oncology, Department of Internal Medicine, Asan Medical Center, Songpa-Gu, Seoul, Republic of Korea. ykkang@amc.seoul.kr
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III